AAAAAA
Results:
1-23
|
Results: 23
Authors:
Dweck, A
Abrahamov, A
Hadas-Halpern, I
Zimran, A
Elstein, D
Citation: A. Dweck et al., Wandering spleen in a young girl with Gaucher disease, ISR MED ASS, 3(8), 2001, pp. 623-624
Authors:
Goitein, O
Elstein, D
Abrahamov, A
Hadas-Halpern, I
Melzer, E
Kerem, E
Zimran, A
Citation: O. Goitein et al., Lung involvement and enzyme replacement therapy in Gaucher's disease, QJM-MON J A, 94(8), 2001, pp. 407-415
Authors:
Pines, G
Morag, A
Elstein, D
Abrahamov, A
Zimran, A
Citation: G. Pines et al., Viral infections and phenotypic heterogeneity in Gaucher disease, BL CELL M D, 27(2), 2001, pp. 358-361
Authors:
Pines, G
Morag, A
Elstein, D
Abrahamov, A
Zimran, A
Citation: G. Pines et al., Viral infections and phenotypic heterogeneity in Gaucher disease, BL CELL M D, 27(2), 2001, pp. 358-361
Authors:
Lebel, E
Itzchaki, M
Hadas-Halpern, I
Zimran, A
Elstein, D
Citation: E. Lebel et al., Outcome of total hip arthroplasty in patients with Gaucher disease, J ARTHROPLA, 16(1), 2001, pp. 7-12
Authors:
Halle, D
Elstein, D
Geudalia, D
Sasson, A
Shinar, E
Schlesinger, M
Zimran, A
Citation: D. Halle et al., High prevalence of complement C7 deficiency among healthy blood donors of Moroccan Jewish ancestry, AM J MED G, 99(4), 2001, pp. 325-327
Authors:
Margalit, M
Attias, E
Attias, D
Elstein, D
Zimran, A
Matzner, Y
Citation: M. Margalit et al., Effect of ozone on neutrophil function in vitro, CLIN LAB H, 23(4), 2001, pp. 243-247
Authors:
Platt, FM
Jeyakumar, M
Andersson, U
Priestman, DA
Dwek, RA
Butters, TD
Cox, TM
Lachmann, RH
Hollak, C
Aerts, JMFG
Van Weely, S
Hrebicek, M
Moyses, C
Gow, I
Elstein, D
Zimran, A
Citation: Fm. Platt et al., Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy, J INH MET D, 24(2), 2001, pp. 275-290
Authors:
Elstein, D
Abrahamov, A
Hadas-Halpern, I
Zimran, A
Citation: D. Elstein et al., Gaucher's disease, LANCET, 358(9278), 2001, pp. 324-327
Authors:
Elstein, D
Abrahamov, A
Hadas-Halpern, I
Zimran, A
Citation: D. Elstein et al., Clinical monitoring after cessation of enzyme replacement therapy in M. Gaucher - Reply, BR J HAEM, 113(4), 2001, pp. 1086-1087
Authors:
Elstein, D
Aya, A
Hadas-Halpern, I
Zimran, A
Citation: D. Elstein et al., Interruption in enzyme replacement therapy for Gaucher disease - Reply, BR J HAEM, 113(4), 2001, pp. 1088-1089
Authors:
Lebel, E
Itzchaki, M
Elstein, D
Hadas-Halpern, I
Abrahamov, A
Zimran, A
Citation: E. Lebel et al., Managing Gaucher, ISR MED ASS, 2(3), 2000, pp. 260-260
Authors:
Zimran, A
Abrahamov, A
Elstein, D
Citation: A. Zimran et al., Children with type I Gaucher disease: Growing into adulthood with and without enzyme therapy, ISR MED ASS, 2(2), 2000, pp. 80-81
Authors:
Aharoni, D
Hadas-Halpern, I
Elstein, D
Zimran, A
Citation: D. Aharoni et al., Huge subcapsular splenic hematoma tn a patient with Gaucher disease, ISR MED ASS, 2(1), 2000, pp. 61-62
Authors:
Elstein, D
Renbaum, P
Levy-Lahad, E
Zimran, A
Citation: D. Elstein et al., Incidence of thrombophilia in patients with Gaucher disease, AM J MED G, 95(5), 2000, pp. 429-431
Authors:
Cox, T
Lachmann, R
Hollak, C
Aerts, J
van Weely, S
Hrebicek, M
Platt, F
Butters, T
Dwek, R
Moyses, C
Gow, I
Elstein, D
Zimran, A
Citation: T. Cox et al., Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis, LANCET, 355(9214), 2000, pp. 1481-1485
Authors:
Elstein, D
Zimran, A
Citation: D. Elstein et A. Zimran, IV epoprostenol in Gaucher's disease, CHEST, 117(6), 2000, pp. 1821-1821
Authors:
Elstein, D
Abrahamov, A
Hadas-Halpern, I
Zimran, A
Citation: D. Elstein et al., Withdrawal of enzyme replacement therapy in Gaucher's disease, BR J HAEM, 110(2), 2000, pp. 488-492
Authors:
Lebel, E
Itzchaki, M
Elstein, D
Hadas-Halpern, I
Abrahamov, A
Zimran, A
Citation: E. Lebel et al., Skeletal manifestations in Gaucher disease: Presentation and treatment, ISR MED ASS, 1(4), 1999, pp. 267-271
Authors:
Veinot, JP
Elstein, D
Hanania, D
Abrahamov, A
Srivatsa, S
Zimran, A
Citation: Jp. Veinot et al., Gaucher's disease with valve calcification: Possible role of Gaucher cells, bone matrix proteins and integrins, CAN J CARD, 15(2), 1999, pp. 211-216
Authors:
Gillis, S
Hyam, E
Abrahamov, A
Elstein, D
Zimran, A
Citation: S. Gillis et al., Platelet function abnormalities in Gaucher disease patients, AM J HEMAT, 61(2), 1999, pp. 103-106
Authors:
Gielchinsky, Y
Elstein, D
Hadas-Halpern, I
Lahad, A
Abrahamov, A
Zimran, A
Citation: Y. Gielchinsky et al., Is there a correlation between degree of splenomegaly, symptoms and hypersplenism? A study of 218 patients with Gaucher disease, BR J HAEM, 106(3), 1999, pp. 812-816
Authors:
Elstein, D
Abrahamov, A
Hadas-Halpern, I
Zimran, A
Citation: D. Elstein et al., Recommendations for diagnosis, evaluation, and monitoring of patients withGaucher disease, ARCH IN MED, 159(11), 1999, pp. 1254-1255
Risultati:
1-23
|